Adverse events (hot flushes) · women with uterine fibroids
1 finding from 1 review
Haemoglobin level ‐ Haemoglobin level at 12 months Scale from: 0 to 20. · women with uterine fibroids
1 finding from 1 review
Fibroid size · women with uterine fibroids
1 finding from 1 review
Adverse events · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in fibroid related symptoms · women with uterine fibroids
1 finding from 1 review
Change in haemoglobin level from baseline · women with uterine fibroids
2 findings from 1 review
Fibroid size · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
FEV1 change from start of treatment (L) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
FEV1 change from start of treatment (% predicted) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Time to next exacerbation · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Adverse events: number of moderate adverse events · adults and children with cystic fibrosis and P aeruginosa
The intervention showed no clear difference in adverse events: number of moderate adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Sputum density: change in P aeruginosa sputum density (log1₀ CFU/g) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Quality of life: change in CFQ‐R score from start of treatment · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Clinical cure according to criteria established by study authors Mild‐moderate PID · women with PID
It is very uncertain whether regimens containing macrolides (azithromycin) changes clinical cure according to criteria established by study authors… compared with regimens containing tetracycline (doxycycline) (very low certainty).
2 findings from 1 review
RR 1.18 [0.89, 1.55]
Studies not reported
Very low
RR 1.35 [1.1, 1.67]
Studies not reported
Moderate
Clinical cure according to criteria established by study authors Severe PID · women with PID
Regimens containing quinolone showed no clear difference in clinical cure according to criteria established by study authors… compared with regimens containing cephalosporins (low certainty).
1 finding from 1 review
RR 1.06 [0.91, 1.23]
Studies not reported
Low
Microbiological clearance · women with PID
It is very uncertain whether regimens containing quinolone changes microbiological clearance compared with regimens containing cephalosporins (very low certainty).
1 finding from 1 review
RR 0.95 [0.84, 1.08]
Studies not reported
Very low
Laparoscopic evidence of resolution of PID based on physician opinion · women with PID
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of stay · women with PID
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fertility outcome · women with PID
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical cure according to criteria established by study authors Mild‐moderate PID · women with PID
Regimens containing nitroimidazole showed no clear difference in clinical cure according to criteria established by study authors… compared with no nitroimidazole (moderate certainty).
2 findings from 1 review
RR 1.02 [0.95, 1.09]
Studies not reported
Moderate
RR 1.05 [1, 1.12]
Studies not reported
High